BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 37730279)

  • 21. Transcriptomic Evaluation of Pulmonary Fibrosis-Related Genes: Utilization of Transgenic Mice with Modifying p38 Signal in the Lungs.
    Matsuda S; Kim JD; Sugiyama F; Matsuo Y; Ishida J; Murata K; Nakamura K; Namiki K; Sudo T; Kuwaki T; Hatano M; Tatsumi K; Fukamizu A; Kasuya Y
    Int J Mol Sci; 2020 Sep; 21(18):. PubMed ID: 32937976
    [TBL] [Abstract][Full Text] [Related]  

  • 22. YAP1/Twist promotes fibroblast activation and lung fibrosis that conferred by miR-15a loss in IPF.
    Chen Y; Zhao X; Sun J; Su W; Zhang L; Li Y; Liu Y; Zhang L; Lu Y; Shan H; Liang H
    Cell Death Differ; 2019 Sep; 26(9):1832-1844. PubMed ID: 30644438
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The Bleomycin Model of Pulmonary Fibrosis.
    Liu T; De Los Santos FG; Phan SH
    Methods Mol Biol; 2017; 1627():27-42. PubMed ID: 28836192
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Low-dose administration of bleomycin leads to early alterations in lung mechanics.
    Headley L; Bi W; Wilson C; Collum SD; Chavez M; Darwiche T; Mertens TCJ; Hernandez AM; Siddiqui SR; Rosenbaum S; Johnston RA; Karmouty-Quintana H
    Exp Physiol; 2018 Dec; 103(12):1692-1703. PubMed ID: 30260066
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Tissue turnover of collagen type I, III and elastin is elevated in the PCLS model of IPF and can be restored back to vehicle levels using a phosphodiesterase inhibitor.
    Hansen NU; Karsdal MA; Brockbank S; Cruwys S; Rønnow S; Leeming DJ
    Respir Res; 2016 Jul; 17(1):76. PubMed ID: 27411390
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Extracellular Matrix Cross-Linking Enhances Fibroblast Growth and Protects against Matrix Proteolysis in Lung Fibrosis.
    Philp CJ; Siebeke I; Clements D; Miller S; Habgood A; John AE; Navaratnam V; Hubbard RB; Jenkins G; Johnson SR
    Am J Respir Cell Mol Biol; 2018 May; 58(5):594-603. PubMed ID: 29053339
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Quantification of Lung Fibrosis in IPF-Like Mouse Model and Pharmacological Response to Treatment by Micro-Computed Tomography.
    Ruscitti F; Ravanetti F; Bertani V; Ragionieri L; Mecozzi L; Sverzellati N; Silva M; Ruffini L; Menozzi V; Civelli M; Villetti G; Stellari FF
    Front Pharmacol; 2020; 11():1117. PubMed ID: 32792953
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Effects of antisense oligonucleotide to nuclear factor-kappaB on the development of bleomycin-induced pulmonary fibrosis and IL-4 expression therein: experiment with mice].
    Zhang XY; Zhou Y; Liu WQ; Zhao L; Li SQ
    Zhonghua Yi Xue Za Zhi; 2007 Jan; 87(3):195-9. PubMed ID: 17425852
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Usefulness of
    Hiroyama S; Matsunaga K; Ito M; Iimori H; Tajiri M; Nakano Y; Shimosegawa E; Abe K
    Eur J Nucl Med Mol Imaging; 2022 Nov; 49(13):4358-4368. PubMed ID: 35876866
    [TBL] [Abstract][Full Text] [Related]  

  • 30. TREM2 Insufficiency Protects against Pulmonary Fibrosis by Inhibiting M2 Macrophage Polarization.
    Luo Q; Deng D; Li Y; Shi H; Zhao J; Qian Q; Wang W; Cai J; Yu W; Liu J
    Int Immunopharmacol; 2023 May; 118():110070. PubMed ID: 37003186
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Deciphering the molecular mechanisms of Maxing Huoqiao Decoction in treating pulmonary fibrosis via transcriptional profiling and circRNA-miRNA-mRNA network analysis.
    Zhao C; Bu E; Zhang C; Lai R; He J; Guo B; Guo W; Liu L; Pan H
    Phytomedicine; 2023 Jul; 115():154754. PubMed ID: 37087790
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Characterization of the heterogeneity of endothelial cells in bleomycin-induced lung fibrosis using single-cell RNA sequencing.
    Liu X; Qin X; Qin H; Jia C; Yuan Y; Sun T; Chen B; Chen C; Zhang H
    Angiogenesis; 2021 Nov; 24(4):809-821. PubMed ID: 34028626
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Telomerase and telomere length in pulmonary fibrosis.
    Liu T; Ullenbruch M; Young Choi Y; Yu H; Ding L; Xaubet A; Pereda J; Feghali-Bostwick CA; Bitterman PB; Henke CA; Pardo A; Selman M; Phan SH
    Am J Respir Cell Mol Biol; 2013 Aug; 49(2):260-8. PubMed ID: 23526226
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A New Model of Acute Exacerbation of Experimental Pulmonary Fibrosis in Mice.
    Yegen CH; Haine L; Da Costa Ferreira K; Marchant D; Bernaudin JF; Planès C; Voituron N; Boncoeur E
    Cells; 2022 Oct; 11(21):. PubMed ID: 36359778
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Transcriptomic profiling reveals disease-specific characteristics of epithelial cells in idiopathic pulmonary fibrosis.
    Boesch M; Baty F; Brutsche MH; Tamm M; Roux J; Knudsen L; Gazdhar A; Geiser T; Khan P; Hostettler KE
    Respir Res; 2020 Jun; 21(1):165. PubMed ID: 32605572
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Allies or enemies? The effect of regulatory T cells and related T lymphocytes on the profibrotic environment in bleomycin-injured lung mouse models.
    Seyran M; Melanie S; Philip S; Amiq G; Fabian B
    Clin Exp Med; 2023 Aug; 23(4):1075-1088. PubMed ID: 36403186
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The Anti-fibrotic and Anti-inflammatory Potential of Bone Marrow-Derived Mesenchymal Stem Cells and Nintedanib in Bleomycin-Induced Lung Fibrosis in Rats.
    Gad ES; Salama AAA; El-Shafie MF; Arafa HMM; Abdelsalam RM; Khattab M
    Inflammation; 2020 Feb; 43(1):123-134. PubMed ID: 31646446
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A novel genomic signature with translational significance for human idiopathic pulmonary fibrosis.
    Bauer Y; Tedrow J; de Bernard S; Birker-Robaczewska M; Gibson KF; Guardela BJ; Hess P; Klenk A; Lindell KO; Poirey S; Renault B; Rey M; Weber E; Nayler O; Kaminski N
    Am J Respir Cell Mol Biol; 2015 Feb; 52(2):217-31. PubMed ID: 25029475
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Surfactant protein-D regulates effector cell function and fibrotic lung remodeling in response to bleomycin injury.
    Aono Y; Ledford JG; Mukherjee S; Ogawa H; Nishioka Y; Sone S; Beers MF; Noble PW; Wright JR
    Am J Respir Crit Care Med; 2012 Mar; 185(5):525-36. PubMed ID: 22198976
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Matrix Metalloproteinases Retain Soluble FasL-mediated Resistance to Cell Death in Fibrotic-Lung Myofibroblasts.
    Nareznoi D; Konikov-Rozenman J; Petukhov D; Breuer R; Wallach-Dayan SB
    Cells; 2020 Feb; 9(2):. PubMed ID: 32053892
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.